Abstract

Limited chemical shift dispersion represents a significant barrier to studying multistate equilibria of large membrane proteins by 19F NMR. We describe a novel monofluoroethyl 19F probe that dramatically increases the chemical shift dispersion. The improved conformational sensitivity and line shape enable the detection of previously unresolved states in one-dimensional (1D) 19F NMR spectra of a 134 kDa membrane transporter. Changes in the populations of these states in response to ligand binding, mutations, and temperature correlate with population changes of distinct conformations in structural ensembles determined by single-particle cryo-electron microscopy (cryo-EM). Thus, 19F NMR can guide sample preparation to discover and visualize novel conformational states and facilitate image analysis and three-dimensional (3D) classification.
Introduction
The functions of numerous membrane proteins, including transporters, channels, and receptors, require conformational transitions. Insights into the structure and dynamics of the functional states are crucial for mechanistic understanding and therapeutic development.1−3 Crystallography and single-particle cryogenic electron microscopy (cryo-EM) can provide structural snapshots of different states in a protein conformational ensemble, while various bulk4 and single-molecule5−7 approaches can report on dynamics. Nuclear magnetic resonance (NMR) spectroscopy is a powerful tool for studying the dynamics of small proteins. However, NMR sensitivity and resolution decline with the increase of protein size, and probing the dynamics of proteins over 100 kDa, including membrane proteins, by NMR remains challenging.
One-dimensional (1D) 19F NMR using site-specific probes can be effective for this purpose because of its high sensitivity, the absence of background signals, the exquisite responsiveness of 19F chemical shifts to conformational changes, and its compatibility with inexpensive low-field instruments.8−10 Furthermore, 1D 19F NMR is a single-pulse experiment with no heteronuclear magnetization transfer. It can therefore quantify state populations of even weak or broad resonances. The unique advantages of 19F NMR have led to wide-ranging applications in studying membrane protein dynamics,9,11 protein aggregation,12 protein behavior in cells,13 and drug screening.14 Commonly used 19F probes include aromatic fluorine and trifluoromethyl groups. The latter shows faster longitudinal and slower transverse relaxation rates due to fast rotation, leading to higher sensitivity.15 Manglik et al. developed a trifluoromethyl phenyl group, where the phenyl ring functions as a chemical shift dispersion amplifier.16,17 However, the chemical shift dispersion of trifluoromethyl-based probes generally does not exceed 2 ppm,16,18−20 resulting in severe resonance overlap in large proteins. Recently, Boeszoermenyi et al. reported 19F–13C TROSY improving resonance dispersion via a second dimension21 but sacrificing the advantages of the 1D experiment. Therefore, developing 19F probes with improved dispersion, i.e., increased environmental sensitivity, remains a challenge and is essential for expanding 19F NMR applications.17,22,23
Herein, we report a novel cysteine-conjugated monofluoroethyl (mFE) probe exhibiting narrow linewidths and ultrahigh sensitivity to conformational changes with chemical shift dispersion reaching 9 ppm.
19F chemical shifts of aliphatic monofluorides depend on C–C–C–F dihedral angles in addition to local electric fields and van der Waals interactions.24,25 In a trifluoroalkyl probe, all rotamers are equivalent, but in the monofluoroalkyl probe, the gauche- and anti-rotamers, which can exhibit chemical shift differences of up to 14 ppm,25 are not equivalent. Because of the low energy barrier separating the rotamers, they exchange much faster than the NMR time scale,26 giving a population-weighted chemical shift. We hypothesized that for an mFE probe, weak 19F interactions with the local environment of distinct protein conformations might affect the equilibrium of the gauche- and anti-isomers, giving rise to different population-weighted chemical shifts and larger chemical shift dispersions than for a trifluoroethyl (tFE) probe. Such weak interactions should not significantly alter the kinetics of rotamer exchange, which would remain fast on the NMR time scale. Additionally, fluorine chemical shift anisotropy (CSA) is approximately two times lower in mFE than in the tFE group.27 Because 19F transverse relaxation depends quadratically on the CSA, mFE might feature slower relaxation and narrower linewidths.
To test the environmental sensitivity of the novel mFE probe, we used the aspartate transporter GltPh, an excellent model protein because it samples several functional conformations with known structures. GltPh is similar in size to or larger than many membrane receptors, channels, and transporters. As an archaeal homologue of human glutamate transporters, it harnesses energy from sodium gradients to transport aspartate via an “elevator” mechanism.28 It is an obligate homotrimer of 134 kDa molecular weight that can be reconstituted as a protein–micelle particle of ∼300 kDa.29 During transport, the three GltPh protomers function independently,30 undergoing conformational transitions between the outward- and inward-facing states (OFS and IFS), where the substrate-binding site can open to the extracellular solution and cytoplasm, respectively. 19F NMR measurements using mFE-labeled GltPh resolve an unexpectedly complex conformational landscape, demonstrating the power of the new probe and prompting concordant cryo-EM studies that confirm multiple coexisting states. The response of the dominant NMR signals to environmental changes, including temperature, correlates with changes in the ensemble of structures determined by cryo-EM, allowing for provisional assignments of some of the NMR signals to specific structural states. Importantly, our data also suggest that cryo-EM can accurately reflect the effects of temperature and other conditions on conformational equilibria in solution, a subject of considerable controversy.
Results
High Environmental Sensitivity of the mFE Probe
We designed and synthesized deuterated 19F labeling compounds S-(2-fluoroethyl-1,1,2,2-D4) p-toluenethiosulfonate (TsSCD2CD2F) using commercially available reagents (Figure 1a,b). Deuterated probes provide sharper lines resulting from reduced 19F–2H scalar couplings compared to 19F–1H couplings and from the reduced 19F–1H dipole relaxation at the cost of reduced sensitivity due to longer longitudinal relaxation times (T1) and relaxation delays. We then prepared single-cysteine mutants, A380C, A381C, and M385C, of a previously characterized fully functional cysteine-free GltPh variant (termed wild-type, WT, for brevity; see the Materials and Methods Section for details and ref (20)) and a variant with additional gain-of-function mutations R276S/M395R (termed RSMR). The RSMR mutations accelerate transitions between the OFS and IFS20,31 and substrate uptake by ∼8-fold.32 Thiosulfonates are known to react with cysteine thiols selectively, rapidly, and quantitatively (Figure 1c),33 and the observed efficiency of TsSCD2CD2F reacting with a single cysteine of GltPh was near 100% (Figure S1a). All mFE-labeled mutants retained transport activity when reconstituted into liposomes (Figure S1b).
Figure 1.
Synthesis of the mFE probes and site-specific protein labeling. Synthesis of deuterated and protonated mFE probes (a) TsSCD2CD2F and (b) TsSCH2CH2F. (c) Cysteine-specific labeling. (d) Structure of the GltPh trimer with scaffold domains colored tan and the transport domains colored blue. Colored spheres show the sites of single-cysteine mutations A380C (cyan), A381C (magenta), and M385C (yellow). Dashed line indicates the distance between the 19F labels. (e) Elevator transition of the GltPh transport domain from the OFS (left) to IFS (right). Single protomers are shown in the membrane plane, represented by the dotted lines. The bound substrate aspartate is shown as lime spheres. ACN: acetonitrile; DAST: diethylaminosulfur trifluoride; DCM: dichloromethane; X: hydrogen or deuterium; and Ts: toluenesulfonyl.
We next compared the chemical shift dispersion of the deuterated mFE (mFED) and its predecessor tFE probe. We recorded 1D 19F spectra of mFED- and tFE-labeled WT-M385C and RSMR-M385C GltPh in the presence of Na+ ions and aspartate or a competitive blocker (3S)-3-[[3-[[4-(trifluoromethyl)benzoyl]amino]phenyl]methoxy]-l-aspartic acid (TFB-TBOA). As previously reported, the tFE probe exhibited three peaks with a chemical shift dispersion of 1.1 ppm (Figures 2a and S2a).20 In contrast, the mFED spectra collectively featured five peaks, S1–S5, at 25 °C, with respective chemical shifts of ∼ −214.8, 216.0, 216.6, 217.5, and 218.1 ppm (Figures 2b and S2b,c). An analysis of three independently prepared samples showed that peak identification is highly reproducible, with only small deviations in the fitted peak positions, linewidths, and populations (Figure S3). We ascribe a slight upfield shift in the S4 peak in the presence of TFB-TBOA compared with the aspartate-bound spectrum (Figure 2b, compare bottom and top spectra) to a structural difference between the aspartate- and TFB-TBOA-bound transporters.34 When we lowered the temperature below 15 °C to slow down conformational transitions, we observed an additional S6 peak at ∼ −218.5 ppm for RSMR-M385C-mFED (Figure S2). Overall, the mFED resonances covered a range of 3.6 ppm. Ligands, mutations, and temperature affect the S1–S6 peak populations, suggesting that the resonances correspond to distinct structural states of the transporter and that their populations reflect the kinetic and equilibrium properties of the conformational ensemble. The three GltPh protomers function independently,30,35 and the labeling positions on the adjacent protomers are too distant to affect each other (Figure 1d). Therefore, the 19F resonances report on the structural states of individual protomers.
Figure 2.

mFED-labeled GltPh variants show wide chemical shift dispersion. 19F NMR spectra of (a, b) GltPh-M385C and (c, d) GltPh-A380C labeled with (a, c) tFE and (b, d) mFED. From top to bottom, (a, b) WT and RSMR mutants in 100 mM Na+ and 2 mM aspartate (Asp) and the RSMR mutant in 100 mM Na+ and 0.6 mM TFB-TBOA, and (c, d) WT in 400 mM Na+ and 100 mM Na+ and 2 mM aspartate. All spectra were recorded at 25 °C. Raw data are black, fitted spectra are pink, and deconvoluted Lorentzian peaks are blue. The asterisk denotes a signal from the CF3 group of TFB-TBOA. S1–S5 denote resolved resonances of GltPh-M385C-mFED. Δδ is the largest chemical shift difference observed for the labeling site. All 19F NMR spectra here and elsewhere were recorded at least twice on independently prepared protein samples, producing similar results.
We also compared tFE- and mFED-labeled WT-A380C and WT-A381C GltPh mutants bound to Na+ ions only or Na+ ions and aspartate (Figures 2c,d and S4). For both labeling sites, the mFED probe resulted in wider chemical shift dispersion. Strikingly, the spectra of WT-A380C-mFED in the presence and absence of Asp feature seven peaks distributed over 8.9 ppm (Figure 2d), demonstrating the tremendous potential of the probe. To our knowledge, this is the broadest chemical shift dispersion observed and the greatest number of protein states simultaneously resolved using 19F NMR.
The ultrahigh environmental sensitivity of the mFED probe enables the monitoring of conformational equilibria as a function of the physicochemical environment, ligands, and mutations. Moreover, it can reveal hitherto uncharacterized structural states. For example, the multiple peaks observed for the TFB-TBOA-bound RSMR mutant were unexpected, given that it blocks substrate transport. Similarly, 19F NMR spectra of WT-M385C-mFED and RSMR-M385C-mFED bound to the competitive blocker dl-threo-β-benzyloxyaspartic acid (TBOA), from which TFB-TBOA was originally derived, are dominated by two distinct peaks, S4 for WT and S2 for RSMR (TBOA, Figure 3a). We pursued the simpler TBOA-bound spectrum to assess whether these resonances correspond to an OFS or IFS by probing their solvent accessibility using paramagnetic relaxation enhancement (PRE). M385 is solvent-exposed in the OFS but buried on the interface between the transport and scaffold domains in the IFS (Figure 1e).34,36 The addition of the soluble paramagnetic reagent Gd-DTPT-BMA to the TBOA-bound RSMR mutant significantly broadened the S4 but only weakly affected the S2 peak (Figure S5a). Therefore, we assigned S4 to an OFS and S2 to an IFS. Similarly, for the Na+-bound WT, the paramagnetic reagent broadened S4 but not S2 or S3 (Figure S5b), confirming the assignments of S4 and indicating that S3 is also IFS. The observation that the S2 and S3 peaks are intrinsically broader than S4 is also consistent with the faster transverse relaxation expected for a buried M385 site in these states.
Figure 3.

Identification and structural elucidation of new transporter conformations. (a) 19F NMR spectra of WT-M385C-mFED (upper panel) and RSMR-M385C-mFED (bottom panel) in the presence of 100 mM NaCl and 2 mM TBOA. The resonances occurring with similar chemical shifts to those in Figure 2 are labeled S2, S3, and S4. (b) Cryo-EM density maps of TBOA-bound RSMR GltPh mutant protomers in the IFS (left) and OFS (right) structural classes. The corresponding populations are below the maps.
19F NMR-Guided Cryo-EM Imaging to Discover New Conformational States
Our 19F NMR data revealed that the blocker TBOA stabilized the WT transporter in the OFS, consistent with the published cryo-EM structure of this state.34 Unexpectedly, however, the blocker appeared to stabilize the RSMR mutant in an unknown IFS state. To understand the structural origin of this state, we imaged TBOA-bound RSMR by cryo-EM. Following particle alignment with imposed C3 symmetry, we performed symmetry expansion and three-dimensional (3D) classification to sort multiple conformations of the transporter protomers.34,37 We observed 91% protomers in the IFS with a wide-open substrate-binding site occupied by TBOA (Figures 3b and S6, and Table S1; see the Materials and Methods Section for data processing details). The remaining protomers were in the OFS, similar to the TBOA-bound WT (RMSD of 0.646 Å). Because S2 and S4 are the only peaks in the RSMR-M385C-mFED NMR spectrum, we ascribe S2 to the highly populated open IFS and S4 to the minor OFS population observed by cryo-EM. Interestingly, the TBOA-bound WT populated a distinct S3 IFS (Figure 3a). Consistently, a cryo-EM structure of the TBOA-bound WT transporter constrained in the IFS by crosslinking showed a different, more closed conformation34 than the structure we assigned to S2. Thus, the previously unobserved S2 state reveals a new modality of the ligand interaction with the transporter. While the physiological relevance of the S2 state is beyond the scope of this paper, it could represent an open-gate intermediate in the substrate release process.
Synergistic Use of 19F NMR and Cryo-EM in Exploring the Conformation Landscape
Under transport conditions in the presence of sodium and aspartate, 19F NMR spectra of RSMR-M385C-mFED showed that it populates a surprising number of conformational states, manifesting as resonances S1–S6 (Figures 2b and S2b,c). Temperature modulated their populations so that, at 4 °C, we observed all states, with S6 being the most populated, while above 15 °C, S3 became dominant and S6 invisible (Figure S2). Notably, the S6 peak decreased in amplitude and shifted to the left with increasing temperature, suggesting that it exchanges with another peak with rates approaching the NMR time scale of high μs to low ms. Solvent PRE at 15 °C, where S2–S6 are well resolved, resulted in faster T1 relaxations of S4 and S5 but not S2, S3, and S6 resonances (Figures 4 and S7), suggesting that the mFED probe is exposed to the solvent for the former states and buried in the latter. The S1 peak is too small to evaluate by PRE. These results suggest that the RSMR mutant visits at least two OFS-like conformations, S4 and S5, and three different IFSs, S2, S3, and S6, exchanging slower than the NMR time scale. These assignments are consistent with the S2, S3, and S4 assignments described above for the TBOA-bound and Na+-bound transporters (Figures 3 and S6).
Figure 4.
Assignment of IFS and OFS conformations based on solvent PRE effects. 19F NMR spectra (left) were recorded, and T1 relaxation times (right) were measured in 300 mM NaCl and 2 mM Asp at 15 °C. Relaxation data were fitted to monoexponential functions (solid lines). The fitted T1 values are (a) 1.36 ± 0.20, 1.41 ± 0.02, 1.26 ± 0.33, 1.56 ± 0.16, and 1.26 ± 0.09 s for S2, S3, S4, S5, and S6, respectively, in the absence of Gd-DPTA–BMA and (b) 1.15 ± 0.20, 1.04 ± 0.08, 0.39 ± 0.08, 0.42 ± 0.06, and 1.01 ± 0.06 s in the presence of 20 mM Gd-DPTA–BMA. The error bars, estimated as described in the Materials and Methods Section, are too small to see.
The temperature-dependent population changes observed in 19F NMR experiments prompted us to ask whether cryo-EM can recapitulate them and inform the assignment of resonances to structural states. We flash-froze cryo-EM grids of RSMR-M385C-mET preincubated in 500 mM NaCl and 2 mM aspartate at 4, 15, and 30 °C. After data processing, 3D classification of protomers imaged at 4 °C revealed that ∼87% of them fell into IFS classes with variable orientations of the transport domain relative to the scaffold (Figure S8). The remaining ∼13% were in a previously described intermediate OFS (iOFS), in which the transport domain moves inward slightly compared to the OFS. Based on similar transport domain positions, we grouped the IFS classes into IFS-A and IFS-B ensembles with populations of 19 and 67%, respectively (Figures 5 and S8a). The main structural difference between them is that the transport domain packs more tightly against the scaffold in IFS-A but leans away and leaves a detergent-filled gap in IFS-B (Figure S8e). Similar structures were observed crystallographically and termed “locked” and “unlocked”, respectively.31 The increasing temperature had little effect on the population of the iOFS but led to a dramatic increase in IFS-A to ∼82% at 30 °C and a corresponding decrease in IFS-B populations to ∼9% (Figures 5c and S8b).
Figure 5.
State populations observed in 3D classifications of protomers in cryo-EM parallel NMR measurements. (a) NMR spectra of RSMR-M385C-mFED were recorded in the presence of 500 mM NaCl and 2 mM Asp at 4 (top), 15 (middle), and 30 °C (bottom). (b) Representative maps of the four structural classes identified during cryo-EM particle 3D classifications of RSMR-M385C-mFED prepared at 4 °C. (c) Populations of protomers’ 3D classes in samples preincubated at 4, 15, and 30 °C (left). Open circles are results obtained using different tau values and numbers of classes during 3D classifications in RELION (see the Materials and Methods Section for details). The state populations measured in 19F NMR experiments at the same temperatures are shown in the right panel. Errors are from multiple-peak deconvolutions of spectra in OriginPro 2019.
The population shift from IFS-B to IFS-A at higher temperatures observed in cryo-EM parallels the increase of S3 and decrease of S6 in 19F NMR (Figure 5a), strongly suggesting that S3 corresponds to IFS-A and S6 to IFS-B (Figure 5c). Notably, the RSMR trimer crystallized at 4 °C with two protomers in the “unlocked” IFS-B and one protomer in the “locked” IFS-A,31 consistent with the higher IFS-B population observed by NMR and cryo-EM at 4 °C. S4, which corresponds to the OFS, is weakly populated in RSMR but dominant in the WT transporter (Figures 2b and 3a). Consistently, cryo-EM did not identify the OFS in the 4 °C data set. Instead, we only found ∼2% of particles in the OFS in the 15 °C cryo-EM data set, reflecting the challenge in cryo-EM of detecting lowly populated states. S5 likely corresponds to iOFS because it is the only other observed structural state with the solvent-exposed 385C residue. While these assignments are plausible based on solvent exposure and the correlated population changes in the NMR and cryo-EM data, they remain speculative in the absence of direct structural data, such as we previously used to assign NMR signals to the OFS or IFS.20 The identities of the S1 and S2 resonances remain ambiguous. In particular, we did not observe a state in the cryo-EM classifications resembling the TBOA-bound RSMR structure, which populates the S2 peak (Figure 3). Therefore, it is possible that one of the IFS conformations in the ensembles serendipitously shows a chemical shift similar to that of the TBOA-bound RSMR structure. The decrease in the S2 population at higher temperatures, thermodynamically similar to S6, suggests that it might correspond to one of the “unlocked” IFS-B subclasses.
Discussion and Conclusions
Despite decades of efforts to develop biophysical methods to study protein dynamics, monitoring changes in membrane protein samples with more than two states remains challenging. The model protein in this study is a 134 kDa membrane aspartate/sodium symporter, GltPh, which undergoes complex conformational transitions to transport aspartate and coupled sodium ions across the membrane. Resolving multiconformational ensembles of such large membrane proteins using existing NMR methods is difficult. The new mFE 19F probe takes advantage of the unique electronic properties of the monofluoroalkyl group leading to ultrahigh environmental sensitivity and achieving a chemical shift dispersion of ∼9 ppm for GltPh. However, a reduction of the number of chemically equivalent fluorine atoms and an increase in T1 relaxation time make the sensitivity of the mFEH probe only one-sixth that of the tFE probe. The sensitivity of the deuterated mFED version is approximately two-fold lower still.
This new 19F probe constitutes a straightforward and inexpensive tool enabling 19F NMR-guided high-resolution structural determinations by crystallography or cryo-EM. For example, 19F NMR showed that the transport blocker TBOA stabilizes the gain-of-function RSMR mutant of GltPh in a different conformation than the WT. Consequent cryo-EM imaging led to the discovery of a novel conformation of the transporter in the IFS featuring an open substrate gate and a new mode of inhibitor binding.
19F NMR resonances are difficult to assign to specific structural states because their chemical shifts cannot be routinely predicted from even high-resolution structural models and are exquisitely sensitive to the local environment, indirectly reflecting global protein conformations. Previously, we showed that transition-metal-mediated longitudinal PRE could assist with state assignments by evaluating the distance between the 19F label and a double-histidine-coordinated metal ion. Here, we take advantage of enhanced line broadening and T1 relaxation due to the PRE effects of gadolinium compounds in solution to distinguish states with buried and exposed mFE probes. These measurements discriminate between the OFS- and IFS-like states in WT GltPh and its RSMR mutant.
Protein solutions are plunge-frozen for cryo-EM imaging in a process thought to preserve protein conformations, which can then be visualized by 3D classifications of the particles. Factors such as protein adsorption to the grids, surface tension, and temperature changes during freezing may shift the conformation equilibrium. In addition, data processing and parameters used in classifications can affect the obtained populations of 3D classes.38 Therefore, whether the class distributions reflect state populations in solutions is unclear. Here, for the first time, we evaluated the reliability of the state populations obtained from 3D classifications of EM-imaged particles. We found that the state populations determined by cryo-EM match well with those measured by 19F NMR. For example, the IFS and OFS populations of TBOA-bound RSMR were 95 and 5% in 19F NMR and 91 and 9% in cryo-EM, respectively. There was also good correspondence in complex ensembles of the aspartate-bound RSMR mutant preincubated at different temperatures. We observed a temperature-dependent correlated population increase of the main S3 resonance and the cryo-EM IFS-A structural ensemble and a corresponding decrease in the S6 resonance and the IFS-B ensemble.
Structural determination by cryo-EM and accurate state populations measured by 19F NMR provide a novel means to correlate the structural and thermodynamic properties of membrane proteins. For example, our results suggest that IFS-B has a dramatically lower enthalpy than IFS-A, resulting in the steep temperature dependence of the IFS-B to IFS-A transition. The lower IFS-B enthalpy must be associated with breaking the protein interface between the transport and scaffold domains and inserting detergent moieties into the gap. The detailed analysis of the phenomenon is beyond the scope of the paper. Nevertheless, our results show that even modest temperature changes can have profound effects on the observed conformational ensemble of a membrane protein, a feature characteristic, for example, of temperature-sensing ion channels.3919F NMR is ideally suited to probe the temperature dependence of protein equilibria and might facilitate the study of the thermodynamics of protein-bilayer interactions.
19F NMR can detect conformations of RSMR-M385C-mEF present at only a few percent, such as the S4 peak, attributed to the OFS. Such weakly populated states might be important functional intermediates, yet they are difficult to isolate during the 3D classification of cryo-EM-imaged particles, especially when several conformations coexist. Thus, we only found the OFS class in the 15 °C cryo-EM data set, where 19F NMR suggests its population is slightly higher than at 4 or 30 °C and where we collected the largest number of particles. Therefore, the ability of 19F NMR to visualize rare states provides a means to assess their populations and optimize conditions that can enrich them for high-resolution structural elucidation.
In summary, mFE chemical shift dispersion significantly exceeds that of tFE, enabling a more detailed and quantitative description of protein conformational ensembles and guiding cryo-EM imaging. Improved peak separation should also facilitate measurements of chemical exchange rates by methods such as EXSY20 and saturation transfer, including CEST.40 Continuously expanding structural methodologies reveal that proteins populate diverse conformational ensembles. For example, a G-protein-coupled adenosine A2A receptor samples at least five distinguishable states during activation.41 Our model protein is similar in size to or larger than many physiologically important receptors, transporters, and ion channels. The new 19F probe should greatly facilitate mechanistic studies of such proteins.
Materials and Methods
Synthesis of S-(2-Fluoroethyl-1,1,2,2-D4) P-Toluenethiosulfonate
To a solution of potassium p-toluenethiosulfonate (678 mg, TCI Chemical) in dry acetonitrile (10 mL) was added 2-bromoethanol-1,1,2,2-d4 (240 μL, Cambridge Isotope Laboratories) under argon. The mixture was stirred at 60 °C overnight. The solvent was evaporated under reduced pressure, and the residue was dissolved in 50 mL of ethyl acetate and washed with 0.5 M HCl aqueous solution (2 × 20 mL) and brine. The organic layer was dried over anhydrous Na2SO4 and then evaporated under reduced pressure to give S-(2-hydroxyethyl-1,1,2,2-D4) p-toluenethiosulfonate (600 mg, 85% yield) as an oil. The product was directly used for the next step without further purification.
To a solution of S-(2-hydroxyethyl-1,1,2,2-D4) p-toluenethiosulfonate (480 mg, 2 mmol) in dry dichloromethane (5 mL) precooled to −70 °C 1.5 equiv of diethylaminosulfur trifluoride (3 mL of 1 M solution in dichloromethane, Sigma-Aldrich) was added dropwise under argon. After 10 min of stirring at −70 °C, the flask was warmed to room temperature for 30 min. The reaction was quenched with 0.5 mL of methanol. The reaction mixture was evaporated to dryness and then purified using a flash column (RediSep Rf) using 0–60% petroleum ether/ethyl acetate. The major fraction was collected and evaporated to obtain the pure title compound (220 mg, 45% yield). The identity of the compound was confirmed by NMR. 1H NMR (500 MHz, CDCl3) δ 7.82 (d, J = 8.4 Hz, 2H), δ 7.36 (d, J = 7.7 Hz, 2H), δ 2.46 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 145.40, 141.85, 130.18, 127.24, 81.44–79.32 (J = 171.19 Hz), 34.88 (m), 31.84; 19F NMR (470 MHz, CDCl3) δ −215.25 (m).
Synthesis of S-(2-Fluoroethyl) P-Toluenethiosulfonate
To a solution of potassium p-toluenethiosulfonate (620 mg, 2.7 mmol, TCI Chemical) in dry acetonitrile (10 mL) 1-bromo-2-fluoroethane (203 μL, Accela ChemBio Inc.) was added under argon. The mixture was stirred at 60 °C overnight. The solvent was removed under reduced pressure, and the residue was dissolved in 50 mL of ethyl acetate and washed with 0.5 M HCl aqueous solution (2 × 20 mL) and brine. The organic layer was dried over anhydrous Na2SO4 and evaporated under reduced pressure. The residue was purified by flash column chromatography to give the pure title compound (503 mg, 86% yield) as an oil. The identity of the compound was confirmed by NMR. 1H NMR (500 MHz, CDCl3) δ 7.82 (d, J = 8.2 Hz, 1H), 7.36 (d, J = 8.1 Hz, 1H), 4.61 (t, J = 6.3 Hz, 1H), 4.52 (t, J = 6.3 Hz, 1H), 3.30 (t, J = 6.3 Hz, 1H), 3.26 (t, J = 6.3 Hz, 1H), 2.46 (s, 3H); 13C NMR (126 MHz, CDCl3) δ 145.22, 141.72, 130.01, 127.11, 81.01 (d, J = 172.6 Hz), 35.38 (d, J = 22.7 Hz), 21.70; 19F NMR (471 MHz, CDCl3) δ −213.51 (tt, J = 46.9, 20.4 Hz).
Protein Expression, Purification, and Labeling
The single-cysteine mutations A380C, A381C, and M385C were introduced into the Y215H/E219H cysteine-free GltPh mutant (termed WT here for brevity), where the introduction of double histidine has been shown to not perturb the transport activity significantly.20 The M385C mutation was also introduced into the gain-of-function variant generated by additional R276S/M395R mutations (RSMR for brevity). All constructs were expressed, purified, and labeled as described, with modifications.20,36 In brief, pBAD plasmids encoding constructs with C-terminal thrombin cleavage sites followed by (His)8-tag were transformed into E. coli DH10-B cells (Invitrogen). Cells were grown in LB media at 37 °C to an OD600 of 1.1. The temperature was then set to 30 °C and protein expression was induced by adding 0.2% arabinose (Goldbio). Cells were grown for additional 16 h. The cells were harvested by centrifugation and resuspended in 20 mM HEPES, pH 7.4, 200 mM NaCl, 1 mM l-asp, and 1 mM EDTA. The suspended cells were broken by an Emulsiflex C3 high-pressure homogenizer (Avestin Inc.) in the presence of 0.5 mg/mL lysozyme (Goldbio) and 1 mM phenylmethanesulfonyl fluoride (PMSF, MP Biomedicals). After centrifugation for 15 min at 5000g, the supernatant was centrifuged at 125,000g for 50 min.
For mFE labeling, the membrane pellets were collected and solubilized in a buffer containing 20 mM HEPES, pH 7.4, 200 mM NaCl, 1 mM Asp, 10 mM 2-mercaptoethanol, 40 mM n-dodecyl-β-d-maltopyranoside (DDM, Anatrace, Inc.) for 2 h at 4 °C. The mixture was centrifuged for 50 min at 125,000g. The supernatant was diluted three times with buffer A (20 mM HEPES, pH 7.4, 200 mM NaCl, 1 mM Asp) and incubated with Ni-NTA resin (Qiagen) for 1 h at 4 °C. The resin was washed with six volumes of buffer A supplemented with 1 mM DDM and 25 mM imidazole, and proteins were eluted in buffer A supplemented with 1 mM DDM and 300 mM imidazole. EDTA was added to the collected protein fractions to a final concentration of 0.5 mM. The protein was concentrated to ∼10 mg/mL using concentrators with 100 kDa MW cutoff (Amicon). Protein concentration was determined by ultraviolet (UV) absorbance at 280 nm using the extinction coefficient of 57,400 M–1 cm–1 and MW of 44.7 kDa (protomer). Two molar equivalents of TsSCD2CD2F or TsSCH2CH2F, prepared as stock solutions in DMSO, were added to the protein samples, followed by incubation at 4 °C for 2 h or room temperature for 1 h. Thrombin was added and incubated overnight at room temperature to cleave the (His)8-tag.
For tFE labeling, the membrane pellet was solubilized in a buffer containing 20 mM HEPES, pH 7.4, 200 mM NaCl, 1 mM Asp, 40 mM DDM, and 2 mM 4,4'-dithiodipyridine (DTDP, Sigma-Aldrich). After binding to Ni-NTA resin, the protein–resin slurry was first washed with five volumes of buffer A supplemented with 1 mM DDM. Trifluoroethanethiol (2 mM, Sigma-Aldrich) was added, and the slurry was incubated with mixing at 4 °C overnight. The resin was washed with buffer A supplemented with 1 mM DDM and 25 mM imidazole and then eluted with buffer A supplemented with 1 mM DDM and 300 mM imidazole. The (His)8-tag was cleaved using thrombin at room temperature overnight.
Both mFE- and tFE-labeled proteins were further purified by size exclusion chromatography (SEC) using a Superdex 200 Increase 10/300 GL column (GE Healthcare Life Sciences) in a buffer containing 20 mM HEPES, pH 7.4, 50 mM KCl, and 1 mM DDM. NaCl (100 mM) was added to the protein fractions immediately. The protein was concentrated and supplemented with additional NaCl and ligands as needed. The labeling efficiency was quantified using 1D NMR and found to be quantitative (Figure S1a)
Transport Activity Assay
Unlabeled and mFE-labeled WT GltPh were concurrently reconstituted into liposomes, and initial rates of 3H Asp uptake were measured as previously described.42 Briefly, liposomes were prepared from a 3:1 (w/w) mixture of E. coli polar lipids and egg yolk phosphatidylcholine (Avanti Polar Lipids) in 20 mM HEPES/Tris, pH 7.4, containing 200 mM KCl and 100 mM choline chloride. Liposomes were destabilized by the addition of Triton X-100 at a detergent-to-lipid ratio of 0.5:1 (w/w). GltPh proteins were added at a final protein-to-lipid ratio of 1:2,000 (w/w) and incubated for 30 min at room temperature. Detergents were removed with Bio-Beads SM-2 resin (Bio-Rad) via two incubations at room temperature, one overnight incubation at 4 °C, and two more incubations at room temperature. The proteoliposomes were concentrated to 50 mg/mL and flash-frozen in liquid N2. On the day of the experiment, liposomes were thawed and extruded through 400 nm filters. The uptake reaction was started by diluting the proteoliposomes 100-fold into a reaction buffer containing 20 mM HEPES/Tris pH 7.4, 200 mM KCl, 100 mM NaCl, 1 μM 3H-l-Asp (PerkinElmer), and 0.5 μM valinomycin. Uptake was measured at 2 min at 35 °C. Reactions were quenched by adding 10 volumes of cold buffer containing 20 mM HEPES/Tris pH 7.4, 200 mM KCl, and 100 mM LiCl. Uptakes of the mutants were normalized to the WT protein in each experiment. Each data point is an average of at least two technical replicates, and the data are composed of the results from three independent liposome reconstitutions.
19F NMR Spectroscopy
19F NMR spectra were collected on a Bruker Avance III HD 500 MHz spectrometer equipped with a TCI 1H-19F/13C/15N triple resonance cryogenic probe (Bruker Instruments) tuned for 19F. For mFED-labeled proteins, 50 μM 2-fluoroethanol and 10% D2O were added to the sample and used as a chemical shift reference (−224.22 ppm) and a lock signal, respectively. Typically, 160 μL of the transporter solution at a final concentration of 100–250 μM (protomer) was loaded into a 4 mm Shigemi tube (Shigemi Co., Ltd). 1D 19F NMR spectra were recorded using the standard ZG pulse in the Bruker pulse library, with 2096 points recorded and a spectral width (SW) of 40 ppm. The carrier frequency was set at −220 ppm. The recycle delay was set to 1.5 and 0.9 s for mFED and mFEH, respectively, except when otherwise indicated. The scan numbers were set according to protein and salt concentrations and temperatures between 2 and 30 K (acquisition times ranged from 1 to 14 h) to achieve a satisfactory signal-to-noise ratio. For tFE-labeled proteins, 50 μM trifluoroacetic acid was added to the samples and used as a chemical shift reference (−76.55 ppm), the carrier frequency was set at −70 ppm, and the recycle delay was set to 0.6 s. All of the spectra were recorded without decoupling.
All 1D 19F NMR spectra were processed using MestReNova 12.0.0 software (Mestrelab Research). The free induction decay signals were zero-filled to 8192 points and Fourier transformed after applying a 20 Hz exponential window function. The spectra were baseline-corrected, and the peaks were manually picked. The initial values of peak heights and linewidths were manually set such that their sum approximated the original spectrum. Simulated annealing was used for iterative fitting. During fitting, linewidths were constrained between 20 and 800 Hz, peak positions were constrained within 5% variation, and the peak shapes were set to Lorentzian. The reported linewidth values were obtained by subtracting the line-broadening value of 20 Hz from the fitted linewidth. To test the reliability of the fitting procedure and the reproducibility of the resulting parameters, we recorded spectra of three independently prepared RSMR-M385C-mFED samples in 300 mM NaCl and 2 mM Asp. The obtained fitted values of chemical shifts, linewidths, and state populations showed small standard deviations (Figure S3a,c,e). Additionally, we exported MestReNova-processed spectra and fitted them using the Multiple Peak Fit tool in OriginPro 2019 software (OriginLab), which also reported small fitting errors (Figure S3d).
19F longitudinal relaxation times (T1) were measured by the inversion recovery method. The recycle delays were set to 5 and 2.5 s for mFED and mFEH, respectively. The spectra were processed in MestReNova, imported into OriginPro (OriginLab), and globally fitted using the Global Fit Tool patch. The peaks were picked, and initial estimates of their chemical shifts, linewidths, and heights were set manually. The chemical shift and linewidth values for each peak were held fixed between all spectra in the relaxation series but varied relative to other peaks during fitting. The peak intensities and areas were normalized using values obtained after the longest delay. T1 relaxation times were estimated by fitting the relaxation plots to single exponential functions I = I0 (1 – 2 exp(−t/T1)), where I is the normalized peak intensity and t is the relaxation time.
To explore whether probe deuteration sharpens the resonance peaks as expected, we compared the spectra of deuterated (mFED) and protonated mFE (mFEH) attached to WT-M385C in the presence of saturating Na+ ions, where we observed well-resolved S3 and S4 peaks (Figure S9). Consistent with deuterium reducing the 19F–1H dipole relaxation and peak splitting due to 19F–1H spin–spin coupling, mFED produced sharper peaks than mFEH with a more pronounced effect on the intrinsically sharper S4 peak (Figure S9). However, the longer T1 relaxation times (Figure S9), increasing the recycle delay and reducing sensitivity, offset the benefits of deuteration. If hardware enabling 1H decoupling during 19F detection is available, the protonated mFE probe might be preferable.
Cryo-EM Data Collection
To prepare cryo-grids, 3.5 μL of labeled GltPh protein (4.5 mg/mL) was applied to a glow-discharged QuantiFoil R1.2/1.3 300-mesh gold grid (Quantifoil Micro Tools GmbH) and incubated for 2 min under 100% humidity at the desired temperatures. Following incubation, grids were blotted for 3 s at 0 blot force and plunge-frozen in liquid ethane using a Vitrobot Mark IV (Thermo Fisher Scientific). Cryo-EM imaging data were acquired on a Titan Krios microscope (Thermo Fisher Scientific) operated at 300 kV with a K3 Summit direct electron detector (Gatan, Inc.). Automated data collection was carried out in super-resolution mode with a magnification of 105,000×, which corresponds to a calibrated pixel size of 0.852 Å on the specimen and 0.426 Å for super-resolution images. An energy slit width of 20 eV was used throughout the collection. For the TBOA-bound RSMR sample, movies were collected using Leginon43 at a total dose of 52.88 e–/Å2 distributed over 48 frames (1.102 e–/Å2/frame) with an exposure time of 2.40 s (50 ms/frame) and a defocus range of 1.3 −2.0 μm. A total of 8100 movies were collected. For the Asp-bound RSMR grids made at 4 °C, movies had a total dose of 50.94 e–/Å2 distributed over 48 frames (1.061 e–/Å2/frame) with an exposure time of 2.40 s (50 ms/frame) and a defocus range of 1.3–1.5 μm. A total of 5267 movies were collected. For the Asp-bound RSMR grids prepared at 15 °C, movies had a total dose of 58.57 e–/Å2 distributed over 50 frames (1.171 e–/Å2/frame) with an exposure time of 2 s (40 ms/frame) and a defocus range of 0.9–1.9 μm. A total of 14,132 movies were collected. For the Asp-bound RSMR grids prepared at 30 °C, movies had a total dose of 56.04 e–/Å2 distributed over 40 frames (1.401 e–/Å2/frame) with an exposure time of 1.6 s (40 ms/frame) and a defocus range of 1.3–1.6 μm. A total of 5823 movies were collected.
Image Processing
The frame stacks were motion corrected using MotionCor244 with 2× binning, and contrast transfer function (CTF) estimation was performed using CTFFIND4.1.45 Further processing steps were carried out using RELION (REgularized LIkelihood OptimizatioN) 3.0.8 or 3.1.0 and cryoSPARC 3.0 or 3.2.46,47 Particles were picked from micrographs using the Laplacian-of-Gaussian (LoG) picker, aiming for ∼2000 picks per micrograph. These particles were extracted using a box size of 300 pixels with 4× binning and imported into cryoSPARC. Following one round of two-dimensional (2D) classification to remove artifacts, the particles underwent three rounds of heterogeneous refinement in C1 using eight classes. Seven classes were noise volumes created by one iteration of ab initio, and one was an unmasked 3D volume obtained from a complete ab initio run. The particles were converted to the RELION format using PyEM48 and re-extracted at full box size. These particles were reimported into cryoSPARC and underwent one round of nonuniform (NU) refinement using C3 symmetry.49 These particles were converted back to the RELION format for Bayesian polishing with parameters obtained using 5000 random particles.50 The polished particles were reimported into cryoSPARC and subjected to one round of NU refinement in C3 with both local and global CTF refinement options turned on. The particles were again polished in RELION using an expanded box size of 384 pixels, reimported into cryoSPARC, and subjected to one round of NU refinement with C3 symmetry and local and global CTF refinement options turned on. The particles were then C3 symmetry-expanded and subjected to a focused 3D classification in RELION. The local mask was generated by UCSF Chimera51 using a combination of OFS (chain A of PDB model 2NWX) and IFS (chain A of PDB model 3KBC). The tau value was set between 10 and 40 depending on the job. The 3D class populations were calculated by dividing the particle number in the individual class or a group of similar classes by the total number of C3 symmetry-expanded particles. The particles from the individual classes or combined similar classes were imported separately into cryoSPARC and subjected to local refinement using the mask and map obtained from the most recent NU refinement.
Model Building and Refinement
Crystal or cryo-EM structures were used as initial models and docked into the density maps using UCSF Chimera. The models were first real-space refined in PHENIX.52 Misaligned regions were manually rebuilt, and missing side chains and residues were added in COOT.53 Models were iteratively refined with applied secondary structure restraints and validated using MolProbity.54 To cross-validate models, all atoms in the refined models were randomly displaced by an average of 0.3 Å, and each resulting model was refined against the first half-map obtained from processing. The FSC between the refined models and the first half-maps was calculated and compared to the FSC of the other half-maps. The resulting FSC curves were similar, showing no evidence of overfitting (Figure S10). The structural figures were prepared in UCSF Chimera and PyMOL (DeLano Scientific).
Acknowledgments
The authors thank Dr. M. Goger and Dr. S. Bhattacharya for their help with setting up NMR. The authors thank Dr. B. Wang, Dr. A. Paquette, and Dr. W. Rice at the NYU cryo-EM facility for help with electron microscopy data collection. The authors also thank W. Eng and E. Wu for assistance with protein expression and Dr. Z. Shen for assistance with chemical synthesis. This work was supported by NIH grants R37NS085318 and R01NS064357 (O.B.), RF1AG066493 and R35 GM136686 (D.E.), F32 NS102325 (K.R.), and S10OD016320 and S10OD028556 (C.B.). O.B., D.E., and C.B. are members of the New York Structural Biology Center (NYSBC), which is supported in part by NIH Grant P41 GM118302 (CoMD/NMR: Center on Macromolecular Dynamics by NMR Spectroscopy), ORIP/NIH facility improvement grant CO6RR015495, and NIH grant S10OD018509.
Supporting Information Available
The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/jacs.3c01003.
Characterization of labeling efficiency and transport activity assay (Figure S1); additional spectral and structural results (Figures S2–S10); cryo-EM data collection, map and model validation statistics for PDB entry 7UG0, 7UGJ, 7UGD, 7UGV, 7UGX, 7UH6, and 7UH3 (Figure S10 and Table S1); and NMR characterization of synthesized labeling compounds (PDF)
Author Present Address
⊥ iCarbonX (Shenzhen) Co., Ltd., Shenzhen, 518000, China
The authors declare no competing financial interest.
Supplementary Material
References
- Lee Y.; Lazim R.; Macalino S. J. Y.; Choi S. Importance of protein dynamics in the structure-based drug discovery of class A G protein-coupled receptors (GPCRs). Curr. Opin. Struct. Biol. 2019, 55, 147–153. 10.1016/j.sbi.2019.03.015. [DOI] [PubMed] [Google Scholar]
- Peng J. W. Communication Breakdown: Protein Dynamics and Drug Design. Structure 2009, 17, 319–320. 10.1016/j.str.2009.02.004. [DOI] [PubMed] [Google Scholar]
- Sekhar A.; Kay L. E. An NMR View of Protein Dynamics in Health and Disease. Annu. Rev. Biophys. 2019, 48, 297–319. 10.1146/annurev-biophys-052118-115647. [DOI] [PubMed] [Google Scholar]
- Palmer A. G. NMR Characterization of the Dynamics of Biomacromolecules. Chem. Rev. 2004, 104, 3623–3640. 10.1021/cr030413t. [DOI] [PubMed] [Google Scholar]
- Lerner E.; Cordes T.; Ingargiola A.; Alhadid Y.; Chung S.; Michalet X.; Weiss S. Toward dynamic structural biology: Two decades of single-molecule Förster resonance energy transfer. Science 2018, 359, 288 10.1126/science.aan1133. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lewis J. H.; Lu Z. Resolution of ångström-scale protein conformational changes by analyzing fluorescence anisotropy. Nat. Struct. Mol. Biol. 2019, 26, 802–807. 10.1038/s41594-019-0274-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Heath G. R.; Scheuring S. Advances in high-speed atomic force microscopy (HS-AFM) reveal dynamics of transmembrane channels and transporters. Curr. Opin. Struct. Biol. 2019, 57, 93–102. 10.1016/j.sbi.2019.02.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Danielson M. A.; Falke J. J. Use of 19F NMR to probe protein structure and conformational changes. Annu. Rev. Biophys. Biomol. Struct. 1996, 25, 163–195. 10.1146/annurev.bb.25.060196.001115. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Didenko T.; Liu J. J.; Horst R.; Stevens R. C.; Wüthrich K. Fluorine-19 NMR of integral membrane proteins illustrated with studies of GPCRs. Curr. Opin. Struct. Biol. 2013, 23, 740–747. 10.1016/j.sbi.2013.07.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Di Pietrantonio C.; Pandey A.; Gould J.; Hasabnis A.; Prosser R. S.. Understanding Protein Function Through an Ensemble Description: Characterization of Functional States by 19F NMR. In Methods in Enzymology; Elsevier, 2019; Vol. 615, pp 103–130. [DOI] [PubMed] [Google Scholar]
- Picard L.-P.; Prosser R. S. Advances in the study of GPCRs by 19F NMR. Curr. Opin. Struct. Biol. 2021, 69, 169–176. 10.1016/j.sbi.2021.05.001. [DOI] [PubMed] [Google Scholar]
- Suzuki Y.; Brender J. R.; Soper M. T.; Krishnamoorthy J.; Zhou Y.; Ruotolo B. T.; Kotov N. A.; Ramamoorthy A.; Marsh E. N. G. Resolution of Oligomeric Species during the Aggregation of Aβ1–40 Using 19F NMR. Biochemistry 2013, 52, 1903–1912. 10.1021/bi400027y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhu W.; Guseman A. J.; Bhinderwala F.; Lu M.; Su X. C.; Gronenborn A. M. Visualizing Proteins in Mammalian Cells by 19F NMR Spectroscopy. Angew. Chem., Int. Ed. 2022, 61, e202201097 10.1002/anie.202201097. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Buchholz C. R.; Pomerantz W. C. K. 19F NMR viewed through two different lenses: ligand-observed and protein-observed 19F NMR applications for fragment-based drug discovery. RSC Chem. Biol. 2021, 2, 1312–1330. 10.1039/D1CB00085C. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rashid S.; Lee B. L.; Wajda B.; Spyracopoulos L. Side-Chain Dynamics of the Trifluoroacetone Cysteine Derivative Characterized by 19F NMR Relaxation and Molecular Dynamics Simulations. J. Phys. Chem. B 2019, 123, 3665–3671. 10.1021/acs.jpcb.9b01741. [DOI] [PubMed] [Google Scholar]
- Manglik A.; Kim T. H.; Masureel M.; Altenbach C.; Yang Z.; Hilger D.; Lerch M. T.; Kobilka T. S.; Thian F. S.; Hubbell W. L.; Prosser R. S.; Kobilka B. K. Structural Insights into the Dynamic Process of β2-Adrenergic Receptor Signaling. Cell 2015, 161, 1101–1111. 10.1016/j.cell.2015.04.043. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ye L.; Larda S. T.; Frank Li Y. F.; Manglik A.; Prosser R. S. A comparison of chemical shift sensitivity of trifluoromethyl tags: optimizing resolution in 19F NMR studies of proteins. J. Biomol. NMR 2015, 62, 97–103. 10.1007/s10858-015-9922-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liu J. J.; Horst R.; Katritch V.; Stevens R. C.; Wuthrich K. Biased signaling pathways in β2-adrenergic receptor characterized by 19F-NMR. Science 2012, 335, 1106–1110. 10.1126/science.1215802. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Frei J. N.; Broadhurst R. W.; Bostock M. J.; Solt A.; Jones A. J. Y.; Gabriel F.; Tandale A.; Shrestha B.; Nietlispach D. Conformational plasticity of ligand-bound and ternary GPCR complexes studied by 19F NMR of the beta1-adrenergic receptor. Nat. Commun. 2020, 11, 669 10.1038/s41467-020-14526-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Huang Y.; Wang X.; Lv G.; Razavi A. M.; Huysmans G. H. M.; Weinstein H.; Bracken C.; Eliezer D.; Boudker O. Use of paramagnetic 19F NMR to monitor domain movement in a glutamate transporter homolog. Nat. Chem. Biol. 2020, 16, 1006–1012. 10.1038/s41589-020-0561-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Boeszoermenyi A.; Chhabra S.; Dubey A.; Radeva D. L.; Burdzhiev N. T.; Chanev C. D.; Petrov O. I.; Gelev V. M.; Zhang M.; Anklin C.; Kovacs H.; Wagner G.; Kuprov I.; Takeuchi K.; Arthanari H. Aromatic 19F-13C TROSY: a background-free approach to probe biomolecular structure, function, and dynamics. Nat. Methods 2019, 16, 333–340. 10.1038/s41592-019-0334-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ycas P. D.; Wagner N.; Olsen N. M.; Fu R.; Pomerantz W. C. K. 2-Fluorotyrosine is a valuable but understudied amino acid for protein-observed 19F NMR. J. Biomol. NMR 2020, 74, 61–69. 10.1007/s10858-019-00290-0. [DOI] [PubMed] [Google Scholar]
- Wang X.; Zhao W.; Al-Abdul-Wahid S.; Lu Y.; Cheng T.; Madsen J. J.; Ye L. Trifluorinated Keto-Enol Tautomeric Switch in Probing Domain Rotation of a G Protein-Coupled Receptor. Bioconjugate Chem. 2021, 32, 99–105. 10.1021/acs.bioconjchem.0c00670. [DOI] [PubMed] [Google Scholar]
- de Dios A. C.; Oldfield E. Evaluating 19F Chemical Shielding in Fluorobenzenes: Implications for Chemical Shifts in Proteins. J. Am. Chem. Soc. 1994, 116, 7453–7454. 10.1021/ja00095a077. [DOI] [Google Scholar]
- Feeney J.; McCormick J. E.; Bauer C. J.; Birdsall B.; Moody C. M.; Starkmann B. A.; Young D. W.; Francis P.; Havlin R. H.; Arnold W. D.; Oldfield E. 19F Nuclear Magnetic Resonance Chemical Shifts of Fluorine Containing Aliphatic Amino Acids in Proteins: Studies on Lactobacillus casei Dihydrofolate Reductase Containing (2S,4S)-5-Fluoroleucine. J. Am. Chem. Soc. 1996, 118, 8700–8706. 10.1021/ja960465i. [DOI] [Google Scholar]
- Beguin C. G.; Dupeyre R. Nuclear spin relaxation in benzyl fluoride. I. 2H relaxation for internal rotational barrier determination and 1H and 19F intra- and intermolecular relaxation in pure benzyl fluoride. J. Magn. Reson. 1981, 44, 294–313. 10.1016/0022-2364(81)90172-4. [DOI] [Google Scholar]
- Grage S. L.; Dürr U. H. N.; Afonin S.; Mikhailiuk P. K.; Komarov I. V.; Ulrich A. S. Solid state 19F NMR parameters of fluorine-labeled amino acids. Part II: aliphatic substituents. J. Magn. Reson. 2008, 191, 16–23. 10.1016/j.jmr.2007.11.016. [DOI] [PubMed] [Google Scholar]
- Drew D.; Boudker O. Shared Molecular Mechanisms of Membrane Transporters. Annu. Rev. Biochem. 2016, 85, 543–572. 10.1146/annurev-biochem-060815-014520. [DOI] [PubMed] [Google Scholar]
- Yernool D.; Boudker O.; Folta-Stogniew E.; Gouaux E. Trimeric Subunit Stoichiometry of the Glutamate Transporters from Bacillus caldotenax and Bacillus stearothermophilus. Biochemistry 2003, 42, 12981–12988. 10.1021/bi030161q. [DOI] [PubMed] [Google Scholar]
- Ruan Y.; Miyagi A.; Wang X.; Chami M.; Boudker O.; Scheuring S. Direct visualization of glutamate transporter elevator mechanism by high-speed AFM. Proc. Natl. Acad. Sci. U.S.A. 2017, 114, 1584–1588. 10.1073/pnas.1616413114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Akyuz N.; Georgieva E. R.; Zhou Z.; Stolzenberg S.; Cuendet M. A.; Khelashvili G.; Altman R. B.; Terry D. S.; Freed J. H.; Weinstein H.; Boudker O.; Blanchard S. C. Transport domain unlocking sets the uptake rate of an aspartate transporter. Nature 2015, 518, 68–73. 10.1038/nature14158. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Huysmans G. H. M.; Ciftci D.; Wang X.; Blanchard S. C.; Boudker O. The high-energy transition state of the glutamate transporter homologue GltPh. EMBO J. 2021, 40, e105415 10.15252/embj.2020105415. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kenyon G. L.; Bruice T. W.. Novel Sulfhydryl Reagents. In Methods in Enzymology; Elsevier, 1977; Vol. 47, pp 407–430. [DOI] [PubMed] [Google Scholar]
- Wang X.; Boudker O. Large domain movements through the lipid bilayer mediate substrate release and inhibition of glutamate transporters. eLife 2020, 9, e58417 10.7554/eLife.58417. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Erkens G. B.; Hänelt I.; Goudsmits J. M. H.; Slotboom D. J.; van Oijen A. M. Unsynchronised subunit motion in single trimeric sodium-coupled aspartate transporters. Nature 2013, 502, 119–123. 10.1038/nature12538. [DOI] [PubMed] [Google Scholar]
- Yernool D.; Boudker O.; Jin Y.; Gouaux E. Structure of a glutamate transporter homologue from Pyrococcus horikoshii. Nature 2004, 431, 811–818. 10.1038/nature03018. [DOI] [PubMed] [Google Scholar]
- Reddy K. D.; Ciftci D.; Scopelliti A.; Boudker O. The archaeal glutamate transporter homologue GltPh shows heterogeneous substrate binding. J. Gen. Physiol. 2021, 154, e202213131 10.1085/jgp.202213131. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Geraets J. A.; Pothula K. R.; Schröder G. F. Integrating cryo-EM and NMR data. Curr. Opin. Struct. Biol. 2020, 61, 173–181. 10.1016/j.sbi.2020.01.008. [DOI] [PubMed] [Google Scholar]
- Kwon D. H.; Zhang F.; Suo Y.; Bouvette J.; Borgnia M. J.; Lee S.-Y. Heat-dependent opening of TRPV1 in the presence of capsaicin. Nat. Struct. Mol. Biol. 2021, 28, 554–563. 10.1038/s41594-021-00616-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gao J.; Liang E.; Ma R.; Li F.; Liu Y.; Liu J.; Jiang L.; Li C.; Dai H.; Wu J.; Su X.; He W.; Ruan K. Fluorine Pseudocontact Shifts Used for Characterizing the Protein-Ligand Interaction Mode in the Limit of NMR Intermediate Exchange. Angew. Chem. Int., Ed. 2017, 56, 12982–12986. 10.1002/anie.201707114. [DOI] [PubMed] [Google Scholar]
- Huang S. K.; Pandey A.; Tran D. P.; Villanueva N. L.; Kitao A.; Sunahara R. K.; Sljoka A.; Prosser R. S. Delineating the conformational landscape of the adenosine A2A receptor during G protein coupling. Cell 2021, 184, 1884–1894. 10.1016/j.cell.2021.02.041. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Boudker O.; Ryan R. M.; Yernool D.; Shimamoto K.; Gouaux E. Coupling substrate and ion binding to extracellular gate of a sodium-dependent aspartate transporter. Nature 2007, 445, 387–393. 10.1038/nature05455. [DOI] [PubMed] [Google Scholar]
- Suloway C.; Pulokas J.; Fellmann D.; Cheng A.; Guerra F.; Quispe J.; Stagg S.; Potter C. S.; Carragher B. Automated molecular microscopy: the new Leginon system. J. Struct. Biol. 2005, 151, 41–60. 10.1016/j.jsb.2005.03.010. [DOI] [PubMed] [Google Scholar]
- Zheng S. Q.; Palovcak E.; Armache J. P.; Verba K. A.; Cheng Y.; Agard D. A. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 2017, 14, 331–332. 10.1038/nmeth.4193. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rohou A.; Grigorieff N. CTFFIND4: Fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. 2015, 192, 216–221. 10.1016/j.jsb.2015.08.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zivanov J.; Nakane T.; Forsberg B. O.; Kimanius D.; Hagen W. J. H.; Lindahl E.; Scheres S. H. W. New tools for automated high-resolution cryo-EM structure determination in RELION-3. eLife 2018, 7, e42166 10.7554/eLife.42166. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Punjani A.; Rubinstein J. L.; Fleet D. J.; Brubaker M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 2017, 14, 290–296. 10.1038/nmeth.4169. [DOI] [PubMed] [Google Scholar]
- Asarnow D.; Palovcak E.; Cheng Y.. UCSF pyem v0.5; Zenodo. 2019.
- Punjani A.; Zhang H.; Fleet D. J. Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction. Nat. Methods 2020, 17, 1214–1221. 10.1038/s41592-020-00990-8. [DOI] [PubMed] [Google Scholar]
- Zivanov J.; Nakane T.; Scheres S. H. W. A Bayesian approach to beam-induced motion correction in cryo-EM single-particle analysis. IUCrJ 2019, 6, 5–17. 10.1107/S205225251801463X. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pettersen E. F.; Goddard T. D.; Huang C. C.; Couch G. S.; Greenblatt D. M.; Meng E. C.; Ferrin T. E. UCSF Chimera-A visualization system for exploratory research and analysis. J. Comput. Chem. 2004, 25, 1605–1612. 10.1002/jcc.20084. [DOI] [PubMed] [Google Scholar]
- Afonine P. V.; Grosse-Kunstleve R. W.; Chen V. B.; Headd J. J.; Moriarty N. W.; Richardson J. S.; Richardson D. C.; Urzhumtsev A.; Zwart P. H.; Adams P. D. Phenix.model_vs_data: a high-level tool for the calculation of crystallographic model and data statistics. J. Appl. Crystallogr. 2010, 43, 669–676. 10.1107/S0021889810015608. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Emsley P.; Lohkamp B.; Scott W. G.; Cowtan K. Features and development of Coot. Acta Crystallogr., Sect. D: Biol. Crystallogr. 2010, 66, 486–501. 10.1107/S0907444910007493. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chen V. B.; Arendall W. B. 3rd; Headd J. J.; Keedy D. A.; Immormino R. M.; Kapral G. J.; Murray L. W.; Richardson J. S.; Richardson D. C. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr., Sect. D: Biol. Crystallogr. 2010, 66, 12–21. 10.1107/S0907444909042073. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.



